Waters (NYSE: WAT) shares are down 5.09% in pre-market trading on Monday, July 14, 2025, slipping to $334.94. This marks a notable drop from the previous closing price of $352.91 recorded on the prior trading day.
Waters (WAT) and Becton, Dickinson and Company (BDX) have reached a definitive agreement to merge BD’s Biosciences & Diagnostic Solutions business with Waters in a tax-efficient Reverse Morris Trust transaction valued at around $17.5 billion.
Waters is set to take on approximately $4 billion of additional debt. This deal is projected to be accretive to adjusted EPS in its first year. The transaction is expected to close near the end of the first quarter of calendar year 2026.
